Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Smart scale may boost rehab results for chronic disease patients

NCT ID NCT06119594

Knowledge-focused Sponsor: Assistance Publique - Hôpitaux de Paris Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at whether using a connected scale that measures body composition (not just weight) can improve the physical and mental quality of life for people with chronic diseases. About 90 adults will take part in a 6-week physical activity rehab program. Half will use the smart scale alongside standard care, while the other half will receive standard care alone. Researchers will compare quality of life, fitness, and activity levels at 6 weeks and 6 months.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 90 people

The number the study aims to enrol. It can still change while the study runs.

Started

Aug 2024

Expected to finish

Jun 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patient (male or female) aged 18 and over * Patient able to express free, informed and written consent * Patient participating in the physical activity rehabilitation program at the CIMS of the Hôtel Dieu * Patient suffering from a known, stable and diagnosed chronic disease * Patient autonomous in taking treatments for their ALD * Patient affiliated to a social security system Exclusion Criteria: * Patient under legal protection (guardianship, curatorship) * Patient deprived of liberty by a judicial or administrative decision * Patient with functional limitations that do not allow a physical assessment or result in a walking distance \< 350 m during the HDJ for admission to the program * Patient with suspected cardiac pathology during the HDJ for admission to the program * Patient with episode of decompensation or exacerbation * Patient with a pacemaker or implantable automatic defibrillator * Pregnant women

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Chronic disease are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Chronic Disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Chronic disease

Contacts and locations

Locations

  • Centre d&#39;Investigations en Médecine du Sport - Hôpital Hôtel Dieu

    Paris, 75181 Paris Cedex 04, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.